文献速递妇科生殖医学

宫腔镜下绒毛膜下注射甲氨蝶呤后腹腔镜切除妊娠囊治疗剖宫产瘢痕异位妊娠:一种挑战性病理的创新双重方法

Hysteroscopic subchorionic injection of methotrexate followed by laparoscopic excision of the gestational sac for the management of cesarean scar ectopic pregnancy: an innovative dual approach of a challenging pathology.
PubMed 文献 · Fertil Steril · 2024-04-17

本文介绍一例34岁G2P1001剖宫产史孕妇于孕10周确诊剖宫产瘢痕异位妊娠(CSEP),采用宫腔镜下绒毛膜下注射甲氨蝶呤(MTX)1 mg/kg,待β-hCG正常化后行腹腔镜切除残留妊娠囊并修补子宫缺损,两步骤均在门诊完成,无并发症,随访超声确认瘢痕处空虚。

要点

  • CSEP发生率约1/1800次妊娠,占既往剖宫产女性异位妊娠约6%。
  • 宫腔镜下绒毛膜下注射MTX 1 mg/kg可精准给药并提高胎盘绒毛间隙药物浓度。
  • 待β-hCG正常化后行腹腔镜切除残留妊娠囊并修补子宫缺损,可降低术中出血风险。

核心结论

  • 序贯宫腔镜与腹腔镜方法为CSEP治疗提供了一种确切且有效的微创手术选择。

研究设计与样本

  • 本文为视频展示的创新双步骤技术,报告一例34岁G2P1001剖宫产史孕妇于孕10周确诊CSEP。

主要发现

  • 宫腔镜下绒毛膜下注射MTX 1 mg/kg后,待β-hCG正常化行腹腔镜切除残留妊娠囊并修补子宫缺损,两步骤均在门诊完成,治疗中及治疗后未发现并发症。
  • 随访时患者自述健康状况良好,后续超声确认瘢痕处(isthmocele)空虚。

关键数值与推荐

  • CSEP发生率约为1/1800次妊娠,占既往剖宫产女性异位妊娠约6%。
  • MTX给药剂量为1 mg/kg,经宫腔镜注入胎盘绒毛间隙。
  • 待β-hCG水平正常化后行腹腔镜手术。

临床怎么用

  • 作者认为,该序贯宫腔镜与腹腔镜方法可作为CSEP的确切且有效的微创手术选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe an effective two-step surgical approach for the management of cesarean scar ectopic pregnancies (CSEPs). CSEPs occur at an estimated frequency of 1 in 1,800 pregnancies, constituting approximately 6% of ectopic pregnancies in women with a history of prior cesarean delivery [1, 2]. Despite numerous recommended therapeutic approaches, the most effective treatment strategy remains uncertain [3]. DESIGN: We present an innovative double-step technique for the management of a patient with a CSEP involving hysteroscopic subchorionic injection of methotrexate (MTX), followed by laparoscopic resection of the residual gestational sac and simultaneous repair of the uterine defect. SETTING: Academic tertiary hospital. PATIENT: A 34-year-old G2P1001 with a history of prior cesarean section presented at 10 weeks of gestation. Ultrasound revealed a gestational sac within the niche of the previous cesarean scar, confirming the diagnosis of a CSEP. The patient included in this video gave consent for publication of the video and posting of the video online, including on social media, the journal website, scientific literature websites (such as PubMed, ScienceDirect, and Scopus, among others), and other applicable sites. INTERVENTION: The initial treatment involved hysteroscopic administration of MTX within the placental intervillous spaces, ensuring precise medication delivery. The administered dose of MTX was 1 mg/kg. Following the normalization of beta-human chorionic gonadotrophin (β-hCG) levels, laparoscopic resection of the remaining gestational sac and reconstruction of the uterine wall defect were performed. MAIN OUTCOME MEASURES: We have implemented a management strategy focusing on ectopic pregnancy removal and addressing defect revision. The hysteroscopic approach allows for a clear assessment of the ectopic pregnancy and facilitates precise MTX administration, enhancing its effectiveness by increasing drug concentration within the placental intervillous space. Delaying surgical repair until after the β-hCG levels have decreased reduces the risk of excessive bleeding during the procedure, as lower β-hCG levels are associated with reduced vascularity at the ectopic site. Subsequent laparoscopic resection allows for complete removal of the remaining products of conception and repair of the defect, preserving the uterus and restoring normal anatomy. Compared to other surgical approaches, our two-step approach enables a more precise evaluation of placental implantation, making it a highly effective surgical method. RESULTS: We successfully managed a CSEP using a double-step technique. This involved hysteroscopic injection of subchorionic MTX, followed by laparoscopic resection of the residual gestational sac. Concurrently, we repaired the uterine defect. Both procedures were performed in an outpatient setting without complications detected during or after treatment. At the follow-up visit, the patient reported good health, and subsequent ultrasound confirmed an empty isthmocele. CONCLUSION: This sequential hysteroscopic and laparoscopic approach represents a definitive and effective minimally invasive surgical option for the treatment of CSEP.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Tejerizo Fe MDM, Benitez PE, Gonzalez AM, et al. Hysteroscopic subchorionic injection of methotrexate followed by laparoscopic excision of the gestational sac for the management of cesarean scar ectopic pregnancy: an innovative dual approach of a challenging pathology. Fertil Steril. 2024. PMID: 38636769. doi:10.1016/j.fertnstert.2024.04.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。